Latest news

Insights

Top 10 Drivers Behind Site-less Clinical Trials

Executive Summary Clinical trials are moving beyond the traditional model in which participants repeatedly visit research sites for assessments, monitoring,...
Insights

Multi-Omics and the Next Generation of Drug Discovery

Executive Summary Drug discovery is becoming increasingly dependent on understanding the biological systems that drive disease. Genomics has helped researchers...
Insights

How Foundation Models Are Transforming Drug Discovery

Executive Summary Drug discovery is increasingly becoming a computational problem as pharmaceutical companies generate enormous amounts of biological, chemical, genomic,...
Clinical

BioNTech’s mRNA cancer vaccine fails phase 3 test

A phase 2/3 clinical trial of BioNTech’s mRNA cancer immunotherapy BNT113 has missed one of its dual primary endpoints....
Research & Development

Argenx Scraps Phase III Sjögren Study Over Predicted Efficacy Failure

Argenx has stopped a Phase 3 study testing its...
Commercial

Roche Signs Huge Deal With Rona, Joins ALK7 Obesity Race

Roche has agreed to pay Rona Therapeutics up to...
Insights

Top 10 AI Trends Reshaping Precision Medicine

Executive Summary Precision medicine is moving from a largely genomics-driven model toward a broader approach that combines molecular, clinical, imaging,...
Insights

The Economics of Rare Disease Drug Development

Executive Summary Rare disease drug development presents a distinctive economic challenge for pharmaceutical companies. The scientific need can be substantial, but...
Insights

The Economics of Decentralized Clinical Trials

Executive Summary Decentralized clinical trials are changing how pharmaceutical companies think about the economics of clinical research. Traditional trials often require...
Insights

Top 10 Digital Biomarkers Changing Clinical Research

Executive Summary Clinical research is expanding beyond measurements collected during...
Commercial

Theramex purchases Asieris’ innovative cervical lesion treatment for up to $250 million

Asieris, a China-based company, has agreed to pay up...
Clinical

MimiVax’s brain cancer vaccine misses phase 2b goal, but CEO sees a path forward in younger patients

MimiVax’s cancer vaccine failed to meet the primary endpoint in a phase 2b trial in newly diagnosed glioblastoma, but...
Clinical

Cerevance’s Solengepras Meets Phase 3 Goal in Parkinson’s Disease Trial

Cerevance reported positive topline results from its Phase 3 ARISE trial, showing that its oral investigational therapy solengepras reduced...
Regulatory

FDA Identifies Four Deaths in Newron’s Evenamide Studies as Clinical Hold Continues

Newron Pharmaceuticals said the U.S. Food and Drug Administration (FDA) has identified four deaths among patients treated with its...
Commercial

Life Sciences Voice In Collaboration With Future Pharma EU 2026

Future Pharma Europe returns on 20–21 October 2026 in...
Editorial Team -
Commercial

Roche Signs Huge Deal With Rona, Joins ALK7 Obesity Race

Roche has agreed to pay Rona Therapeutics up to...
Editorial Team -
Commercial

Roche to lay off 300 to 400 employees in product development jobs

Roche’s executives, including CMO (Chief Medical Officer) Levi Garraway, claimed in a recorded video conference with staff acquired by Swiss Newspaper Blick
Commercial

Eli Lilly and Gate Bioscience Sign $856 Million Agreement to Develop Molecular Gates

Eli Lilly has entered into a collaboration with Gate...

Popular

Most popular life news you must read today

View all articles

Commercial

Information Technology

Suki Launches AI Dictation Tool Integrated With Epic and Meditech EHRs

Suki announced Tuesday the release of Suki Dictation, an artificial intelligence-powered dictation solution designed...
Editorial Team -

Claryx Appears From Stealth to Deal with the $45B Hospital-Acquired Infections Issue

Healthcare-related infections remain a persistent challenge for hospitals, affecting roughly one in every 40...
Editorial Team -

J&J’s OTTAV Robotic Surgical System has received FDA market authorization in the U.S.

The U.S. Food and Drug Administration (FDA) granted Johnson & Johnson De Novo clearance...
Editorial Team -

Alnylam Inks $2B Agreement With Inceptive to Change sIRNA Design With AI Leader

Alnylam has entered into a partnership with the scientist instrumental in developing the technology...
Editorial Team -

Regulatory

Regulatory

FDA Identifies Four Deaths in Newron’s Evenamide Studies as Clinical Hold Continues

Newron Pharmaceuticals said the U.S. Food and Drug Administration...
Editorial Team -
Insights

Multi-Omics and the Next Generation of Drug Discovery

Executive Summary Drug discovery is becoming increasingly dependent on understanding...
Insights

How Foundation Models Are Transforming Drug Discovery

Executive Summary Drug discovery is increasingly becoming a computational problem...
Clinical

BioNTech’s mRNA cancer vaccine fails phase 3 test

A phase 2/3 clinical trial of BioNTech’s mRNA cancer...
Clinical

BMS Reports Twin Phase 3 Wins in Lung Disease And Solid Tumor

Bristol Myers Squibb (BMS) has announced positive Phase 3...

Research & Development

Market Access

Manufacturing

Genentech signs a $490 million breast cancer partnership and lays off 103 employees with gRED Rethink

The Roche subsidiary has just announced that the restructuring...
Manufacturing

fda selects seven drugmakers for precheck pilot to accelerate u.s. manufacturing reviews

The U.S. Food and Drug Administration (FDA) has selected...

Manufacturing & RegulatoryPOPULAR
Find Your Perfect Music Festival

Insights

Top 10 Drivers Behind Site-less Clinical Trials

Executive Summary Clinical trials are moving beyond the traditional model...
Editorial Team -
Insights

How Foundation Models Are Transforming Drug Discovery

Executive Summary Drug discovery is increasingly becoming a computational problem...
Editorial Team -